The Global Systemic Amyloidosis Therapeutic Market is estimated to be valued at USD 6.19 Bn in 2024 and is expected to reach USD 10.99 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031. https://www.zupyak.com/p/4485962/t/understanding-the-systemic-amyloidosis-therapeutic-landscape-key-drugs-and-approaches